Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma in Relapse

Explore clinical trials studying Multiple Myeloma in Relapse. Study availability and eligibility vary by location and protocol.

60 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma in Relapse trial results

Recruiting

Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory t(11;14) Multiple Myeloma

NCT05853965

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University Medical Center Hamburg-Eppendorf Hamburg, Ham, Germany
  • Klinikum Chemnitz Chemnitz, Germany
  • Uniklinik Heidelberg Heidelberg, Germany
  • UKSH Lübeck Lübeck, Germany
View Trial Details

Related conditions